Combining Oncolytic Virotherapy and Cytotoxic Therapies to Fight Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|42|6513-6521

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.42, 2014-12, pp. : 6513-6521

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oncolytic Virotherapy for Breast Cancer Treatment

By  

Current Gene Therapy, Vol. 18, Iss. 4, 2018-08 ,pp. : 192-205

Bentham Science Publishers

Access to resources Recommend Favorite

Converting Viral Villains to Cancer Cures: Oncolytic Virotherapy Creeps Closer to the Clinic

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 3, Iss. 11, 2005-01 ,pp. : 8-12

Adis International

Access to resources Recommend Favorite

Telomerase-Specific Oncolytic Virotherapy for Human Cancer with the hTERT Promoter

By  

Current Cancer Drug Targets, Vol. 7, Iss. 2, 2007-03 ,pp. : 191-201

Bentham Science Publishers

Access to resources Recommend Favorite

Synergistic Interaction of Telomerase-Specific Oncolytic Virotherapy and Chemotherapeutic Agents for Human Cancer

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 9, 2012-07 ,pp. : 1809-1816

Bentham Science Publishers

Access to resources Recommend Favorite

Replicative Oncolytic Herpes Simplex Viruses in Combination Cancer Therapies

By  

Current Gene Therapy, Vol. 4, Iss. 1, 2004-03 ,pp. : 41-51

Bentham Science Publishers

Access to resources Recommend Favorite